IRF5 and myeloid sarcoma: Based on two “omics” approaches, NXF1 was identified as one of the IRF5 signaling pathway regulators, and in turn genome-wide association studies have implied the association of IRF5 with several autoimmune diseases, including SLE, Sjogren’s syndrome, inflammatory bowel disease, and MS [29].